Page last updated: 2024-12-07

fenpropidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Fenpropidine is a synthetic compound that acts as an agonist of the nicotinic acetylcholine receptor. It has been studied as a potential treatment for Alzheimer's disease, as it can improve cognitive function in animal models of the disease. However, it has also been shown to have a number of side effects, including nausea, vomiting, and dizziness, which have limited its clinical development. The mechanism of action of fenpropidine is thought to be related to its ability to increase the release of acetylcholine in the brain. Fenpropidine is a relatively new compound, and further research is needed to determine its potential therapeutic value.'

fenpropidine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine : A member of the class of piperidines that is N-isobutylpiperidine in which a hydrogen of one of the methyl groups is replaced by a p-tert-butylphenyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

fenpropidin : A racemate comprising equimolar amounts of (R)- and (S)-fenpropidin. A systemic fungicide, it is used for the control of foliar diseases in cereals and sugar beet. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID91694
CHEMBL ID1889041
CHEBI ID83291
SCHEMBL ID21278
MeSH IDM0174556

Synonyms (41)

Synonym
piperidine, 1-[3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropyl]-
ro 12-3049
piperidine, 1-(3-(4-(1,1-dimethylethyl)phenyl)-2-methylpropyl)-
cga 114900
fenpropidin
brn 1245248
fenpropidine [iso-french]
1-(3-(4-(1,1-dimethylethyl)phenyl)-2-methylpropyl)piperidine
patrol
fenpropidine
fenpropidin [bsi:iso]
1-(3-(4-tert-butylphenyl)-2-methylpropyl)piperidine
NCGC00166202-01
1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine
67306-00-7
C18726
5-20-02-00071 (beilstein handbook reference)
unii-845xw54f31
845xw54f31 ,
CHEMBL1889041
chebi:83291 ,
SCHEMBL21278
DTXSID9058157
(rs)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine
1-[3-(p-tert.-butyl-phenyl)-2-methyl-propyl]-piperidine
n-(3'-(p-tertiary butylphenyl)-2'-methylpropyl)-piperidine
1-[3-(p-tert.butyl-phenyl)-2-methyl-propyl]-piperidine
ro-12-3049
fenpropidin [iso]
fenpropidin [mi]
fenpropidin, pestanal(r), analytical standard
bdbm50487255
DB12728
Q64825
ro12-3049
1-(3-(4-(tert-butyl)phenyl)-2-methylpropyl)piperidine
HY-126200
CS-0092562
EN300-19359813
1-{2-[(4-tert-butylphenyl)methyl]propyl}piperidine
AKOS040744661

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The results were tested against the concentration addition reference model using dose-response surface analyses."( Pesticide cocktails can interact synergistically on aquatic crustaceans.
Cedergreen, N; Nørgaard, KB, 2010
)
0.36
"The results of the binary dose-response surface studies showed that mixtures with prochloraz increased toxicity up to 12-fold compared with what was expected using the reference model concentration addition (CA)."( Pesticide cocktails can interact synergistically on aquatic crustaceans.
Cedergreen, N; Nørgaard, KB, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
piperidines
tertiary amineA compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA polymerase kappa isoform 1Homo sapiens (human)Potency29.93490.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DeltaZea maysIC50 (µMol)3.00000.03001.27673.0000AID1092250
Cycloeucalenol cycloisomeraseZea maysIC50 (µMol)0.20000.20000.33330.4000AID1092249
Sterol-8,7-isomeraseZea maysIC50 (µMol)0.08000.08000.42000.8000AID1092248
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID1271242Antifungal activity against Candida tropicalis ATCC 750 after 72 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271237Antifungal activity against Cryptococcus neoformans ATCC 34664 after 24 to 36 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271262Metabolic stability in mouse liver microsomes after 30 mins by LC-MS/MS analysis2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271243Antifungal activity against Aspergillus niger ATCC 10578 after 48 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271236Antifungal activity against Candida albicans ATCC 10231 after 72 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271233Antifungal activity against Candida albicans ATCC 24433 after 24 to 36 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271263Metabolic stability in human liver microsomes after 30 mins by LC-MS/MS analysis2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271235Antifungal activity against Candida albicans ATCC 10231 after 24 to 36 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271234Antifungal activity against Candida albicans ATCC 24433 after 72 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271241Antifungal activity against Candida tropicalis ATCC 750 after 24 to 36 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271239Antifungal activity against Candida glabrata NCYC 388 after 24 to 36 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271240Antifungal activity against Candida glabrata NCYC 388 after 72 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1092248Inhibition of Zea mays (maize) delta8,delta7-sterol isomerase1989European journal of biochemistry, Nov-20, Volume: 185, Issue:3
Microsomal delta 8,14-sterol delta 14-reductase in higher plants. Characterization and inhibition by analogues of a presumptive carbocationic intermediate of the reduction reaction.
AID1092249Inhibition of Zea mays (maize) cycloeucalenol-obtusifolial isomerase1989European journal of biochemistry, Nov-20, Volume: 185, Issue:3
Microsomal delta 8,14-sterol delta 14-reductase in higher plants. Characterization and inhibition by analogues of a presumptive carbocationic intermediate of the reduction reaction.
AID1271238Antifungal activity against Cryptococcus neoformans ATCC 34664 after 72 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271264Toxicity in human RBC assessed as hemolysis upto 128 ug/ml2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1271244Antifungal activity against Aspergillus niger ATCC 10578 after 72 hrs by broth microdilution method2015ACS medicinal chemistry letters, Nov-12, Volume: 6, Issue:11
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation.
AID1092250Inhibition of Zea mays (maize) microsomal delta 8,14-steroid 14-reductase using delta 8,14-cholestadienol as substrate after 90 min by GC analysis1989European journal of biochemistry, Nov-20, Volume: 185, Issue:3
Microsomal delta 8,14-sterol delta 14-reductase in higher plants. Characterization and inhibition by analogues of a presumptive carbocationic intermediate of the reduction reaction.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's3 (21.43)18.2507
2000's3 (21.43)29.6817
2010's5 (35.71)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.00 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]